EUVIMEDEUVIMED entdecken
Crossref

Tranexamic acid lowers transfusions and readmissions in high‐risk total knee arthroplasty patients, but neurologic risks remain in patients with seizures or visual disturbances

Joshua R Porto iD, Monish S Lavu iD, Christian J Hecht iD, Olivia G Asimakis, David C Kaelber, Atul F Kamath iD

Knee Surgery, Sports Traumatology, Arthroscopy · 2025

DOI: 10.1002/ksa.70124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Knee Surgery, Sports Traumatology, Arthroscopy, 2025. Verfasst von Joshua R Porto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Case Western Reserve University School of Medicine, Cleveland, 44106, Ohio, USA. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Knee, Tranexamic Acid, Blood Transfusion, Seizures. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Clinical and Translational Science Award (CTSA), National Center for Advancing Translational Science (NCATS), National Institutes of Health (NIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Tranexamic acid (TXA) is widely used in total knee arthroplasty (TKA) to reduce perioperative blood loss and transfusions. However, its safety in high‐risk patients remains uncertain. This study evaluates TXA's safety and efficacy in TKA patients with a history of (1) thromboembolic events, (2) renal failure, (3) atrial fibrillation, (4) seizures and (5) visual disturbances.

Methods

A retrospective analysis of the US Collaborative Network within TriNetX examined TKA patients from 2017 to 2023 ( n = 59,057). High‐risk patients were categorised by preexisting risk factors and propensity‐score matched into TXA and non‐TXA groups. Postoperative outcomes, including thromboembolic events, transfusions, renal failure, seizures, visual disturbances, infections, revisions, readmissions and mortality, were compared using odds ratios (OR) with 95% confidence intervals (CIs).

Results

TXA was associated with lower transfusion rates, revisions, readmissions and emergency visits across multiple risk groups. No increased risk of deep vein thrombosis (DVT) or (PE) was observed in patients with prior thrombosis, renal failure, or atrial fibrillation, though ischaemic stroke/transient ischaemic attack (TIA) was higher in those with prior thrombosis (5.6% vs. 3.9%, OR: 1.44, 95% CI: 1.24–1.68). Patients with seizures had higher rates of postoperative seizures (10.4% vs. 7.1%, OR: 1.53, 95% CI: 1.18–1.99) and pulmonary embolism (1.9% vs. 1.0%, OR: 2.02, 95% CI: 1.06–3.85). In those with visual disturbances, TXA was linked to increased postoperative seizures (0.9% vs. 0.4%, OR: 1.97, 95% CI: 1.21–3.19) and visual disturbances (4.2% vs. 3.3%, OR: 1.29, 95% CI: 1.07–1.57).

Conclusions

TXA reduced transfusions, readmissions and revisions in high‐risk TKA patients without increasing DVT or PE risk, though there was a modest increase in stroke/TIA for patients with prior thromboembolism. However, higher postoperative neurologic complications in patients with seizures or visual disturbances warrant further investigation. While TXA can provide benefits across several outcomes, discretion is advised in patients with neurological risk factors to optimise safety. Level of Evidence Level III, retrospective cohort study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthroplasty, Replacement, KneeTranexamic AcidBlood TransfusionSeizuresAntifibrinolytic AgentsPatient ReadmissionBlood Loss, SurgicalHumansRetrospective StudiesFemaleMaleAgedVision DisordersRisk FactorsMiddle AgedPostoperative ComplicationsThromboembolismRenal InsufficiencyAtrial Fibrillation

Stichwörter der Autor:innen

blood conservationhigh‐risk patientsrisktotal knee arthroplastytranexamic acid

Substanzen

Tranexamic AcidAntifibrinolytic Agents

Autor:innen und Institutionen

  • Case Western Reserve University School of Medicine, Cleveland, 44106, Ohio, USA.
  • Department of Orthopaedics, University of Nebraska Medical Center, Omaha, 68115, Nebraska, USA.
  • Departments of Internal Medicine, Pediatrics, and Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, 44106, Ohio, USA.
  • The Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, 44109, Ohio, USA.
  • Cleveland Orthopedic and Spine Institute, Mayfield Heights, 44124, Ohio, USA.

ORCID-Profile: Joshua R Porto, Monish S Lavu, Christian J Hecht, Atul F Kamath

Förderung

  • Clinical and Translational Science Award (CTSA)
  • National Center for Advancing Translational Science (NCATS)
  • National Institutes of Health (NIH)

Zitieren

APA

Porto, J. R., Lavu, M. S., Hecht, C. J., Asimakis, O. G., Kaelber, D. C., & Kamath, A. F. (2025). Tranexamic acid lowers transfusions and readmissions in high‐risk total knee arthroplasty patients, but neurologic risks remain in patients with seizures or visual disturbances. Knee Surgery, Sports Traumatology, Arthroscopy. https://doi.org/10.1002/ksa.70124

Vancouver

Porto JR, Lavu MS, Hecht CJ, Asimakis OG, Kaelber DC, Kamath AF. Tranexamic acid lowers transfusions and readmissions in high‐risk total knee arthroplasty patients, but neurologic risks remain in patients with seizures or visual disturbances. Knee Surgery, Sports Traumatology, Arthroscopy. 2025. doi:10.1002/ksa.70124

BibTeX
@article{Porto2025,
  author = {Porto, Joshua R and Lavu, Monish S and Hecht, Christian J and Asimakis, Olivia G and Kaelber, David C and Kamath, Atul F},
  title = {Tranexamic acid lowers transfusions and readmissions in high‐risk total knee arthroplasty patients, but neurologic risks remain in patients with seizures or visual disturbances},
  journal = {Knee Surgery, Sports Traumatology, Arthroscopy},
  year = {2025},
  doi = {10.1002/ksa.70124}
}
Kostenlos starten →